A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.

A biologically active human skin allograft, currently distributed under the brand name TheraSkin(®), was examined for safety and efficacy in the treatment of venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs). The objective was to determine if TheraSkin could serve as a safe and effective alternative to bioengineered skin substitutes such as Apligraf(®) and Dermagraft(®). The authors conducted a retrospective study of 214 consecutive patients seen at the Inova Wound Center (Mt Vernon, Virginia), with either a DFU or a VLU.

The modified Hohmann osteotomy: an alternative joint salvage procedure for hallux rigidus.

The purpose of this study was to evaluate the effectiveness of the modified Hohmann osteotomy for treatment of hallux rigidus. By allowing plantarflexion of the first metatarsal head, this osteotomy was theorized to protect gliding motion and to decompress the joint. Twenty-two patients (25 procedures) were assessed preoperatively and postoperatively for the first metatarsal plantarflexory osteotomy.